Baldwin Lyons Cl B (BWINB) 26.45 $BWINB A.M. Best

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Baldwin Lyons Cl B (BWINB) 26.45 $BWINB

A.M. Best Affirms Ratings of the Members of the Baldwin & Lyons Group
BusinessWire - Wed Jun 15, 9:56AM CDT
A.M. Best has affirmed the financial strength rating (FSR) of A+ (Superior) and the issuer credit ratings (ICR) of "aa-" of Protective Insurance Company (PIC) and its wholly owned subsidiary, Sagamore Insurance Company (Sagamore). In addition, A.M. Best has affirmed the FSR of A (Excellent) and the ICR of "a" of PIC's other wholly owned, separately rated subsidiary, Protective Specialty Insurance Company (PSIC). Collectively, these three companies are referred to as the Baldwin & Lyons Group (the group). Concurrently, A.M. Best has affirmed the ICR of "a-" of the group's ultimate publicly traded parent, Baldwin & Lyons, Inc. (B&L) [NASDAQ: BWINA and BWINB]. The outlook for each of these ratings is stable. All companies are domiciled in Carmel, IN.
BWINB: 26.45 (-0.04), BWINA: 24.74 (+0.04)

Baldwin & Lyons, Inc. Announces Second Quarter 2016 Earnings Release Date and Conference Call
GlobeNewswire - Fri Jun 03, 7:00AM CDT
Baldwin & Lyons, Inc. (Nasdaq:BWINA) (Nasdaq:BWINB), today announced that management has scheduled its quarterly conference call for Thursday August 4, 2016, at 11:00 AM ET (New York time) to discuss results for the second quarter ended June 30, 2016. Results will be released prior to the opening of the financial markets on August 4, 2016, and will be available on the company's website at www.baldwinandlyons.com upon release.
BWINB: 26.45 (-0.04), BWINA: 24.74 (+0.04)

Baldwin & Lyons Appoints W. Randall Birchfield Chief Executive Officer
GlobeNewswire - Thu May 19, 3:00PM CDT
Appoints Michael J. Case Chief Operating Officer
BWINB: 26.45 (-0.04), BWINA: 24.74 (+0.04)

Baldwin & Lyons Announces Quarterly Dividend
GlobeNewswire - Tue May 10, 2:14PM CDT
Baldwin & Lyons, Inc. (Nasdaq:BWINA) (Nasdaq:BWINB) announces that at its regular quarterly meeting, the Board of Directors of Baldwin & Lyons, Inc. declared a regular quarterly dividend of $.26 per share on the Company's Class A and Class B Common Stock. The dividend per share will be payable June 7, 2016 to shareholders of record on May 24, 2016.
BWINB: 26.45 (-0.04), BWINA: 24.74 (+0.04)

Baldwin & Lyons posts 1Q profit
Automated Insights - Thu May 05, 8:19AM CDT
CARMEL, Ind. (AP) _ Baldwin & Lyons Inc. (BWINB) on Thursday reported first-quarter profit of $14.1 million.
BWINB: 26.45 (-0.04), BWINA: 24.74 (+0.04)

Baldwin & Lyons Announces Results for the First Quarter of 2016
GlobeNewswire - Thu May 05, 7:00AM CDT
Baldwin & Lyons, Inc. (NASDAQ:BWINA) (NASDAQ:BWINB) today announced record first quarter after tax operating income, defined as net income before investment gains and losses, of $8.3 million, or $.55 per share, for the first quarter of 2016 compared to $3.8 million, or $.26 per share, during the first quarter of 2015. Net investment gains for the first quarter of 2016, which include both realized and unrealized gains in the Company's limited partnership investments, were $5.9 million after tax, or $.39 per share, compared to net investment gains of $2.4 million, or $.16 per share, in the same quarter of 2015. In total, net income for the quarter was $14.1 million, or $.94 per share, which compares to $6.2 million, or $.42 per share, for the prior year's first quarter.
BWINB: 26.45 (-0.04), BWINA: 24.74 (+0.04)

Baldwin & Lyons, Inc. Announces First Quarter 2016 Earnings Release Date and Conference Call
GlobeNewswire - Mon Mar 07, 1:30PM CST
Baldwin & Lyons, Inc. (NASDAQ:BWINA) (NASDAQ:BWINB), today announced that management has scheduled its quarterly conference call for Thursday May 5, 2016, at 11:00 AM ET (New York time) to discuss results for the first quarter ended March 31, 2016. Results will be released prior to the opening of the financial markets on May 5, 2016, and will be available on the company's website at www.baldwinandlyons.com upon release.
BWINB: 26.45 (-0.04), BWINA: 24.74 (+0.04)

Baldwin & Lyons Announces Increased Quarterly Dividend
GlobeNewswire - Fri Feb 05, 3:35PM CST
Baldwin & Lyons, Inc. (Nasdaq:BWINA) (Nasdaq:BWINB) announces that at its regular quarterly meeting, the Board of Directors of Baldwin & Lyons, Inc. declared an increased regular quarterly dividend of $.26 per share on the Company's Class A and Class B Common Stock, representing a 4% increase. The dividend per share will be payable March 4, 2016 to shareholders of record on February 19, 2016.
BWINB: 26.45 (-0.04), BWINA: 24.74 (+0.04)

Baldwin & Lyons Announces the Election of a Director
GlobeNewswire - Thu Feb 04, 10:02AM CST
Baldwin & Lyons, Inc. (NASDAQ:BWINA) (NASDAQ:BWINB) today announced that Mr. Philip V. Moyles, Jr. was elected to the Board of Directors during the Company's regular quarterly board meeting held on February 3, 2016.
BWINB: 26.45 (-0.04), BWINA: 24.74 (+0.04), MMC: 65.94 (+0.19)

Baldwin & Lyons Announces Results for the Quarter and Twelve Months of 2015
GlobeNewswire - Thu Jan 28, 7:00AM CST
Baldwin & Lyons, Inc. (NASDAQ:BWINA) (NASDAQ:BWINB) today announced quarterly after tax operating income, defined as net income before investment gains and losses, of $4.7 million, or $.31 per share, for the fourth quarter of 2015 compared to $6.9 million, or $.46 per share, during the fourth quarter of 2014. Net investment losses for the fourth quarter of 2015, which include both realized and unrealized gains in the Company's limited partnership investments, were $1.1 million after tax, or $.07 per share, compared to net investment gains of $1.4 million, or $.09 per share, in the same quarter of 2014. In total, net income for the quarter was $3.5 million, or $.24 per share, which compares to $8.2 million, or $.55 per share, for the prior year's fourth quarter.
BWINB: 26.45 (-0.04), BWINA: 24.74 (+0.04)

BUYINS.NET: BWINB SqueezeTrigger Price is $23.80. There is $3,559,312 That Short Sellers Still Need To Cover.
M2 - Thu Jan 21, 3:11AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring Baldwin & Lyons Inc (NASDAQ:BWINB) in real time and just received an alert that BWINB is crossing above its primary SqueezeTrigger Price, the price that a short squeeze can start in any stock. There are 149300 shares that have been shorted at the volume weighted average SqueezeTrigger Price of $23.80. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com .
BWINB: 26.45 (-0.04), BWINA: 24.74 (+0.04)

Baldwin & Lyons, Inc. Announces Fourth Quarter 2015 Earnings Release Date and Conference Call
GlobeNewswire - Tue Dec 08, 1:14PM CST
Baldwin & Lyons, Inc. (NASDAQ:BWINA) (NASDAQ:BWINB), today announced that management has scheduled its quarterly conference call for Thursday January 28, 2016, at 11:00 AM ET (New York time) to discuss results for the fourth quarter ended December 31, 2015. Results will be released prior to the opening of the financial markets on January 28, 2016, and will be available on the company's website at www.baldwinandlyons.com upon release.
BWINB: 26.45 (-0.04), BWINA: 24.74 (+0.04)

Baldwin & Lyons Shares Down 10.2% Since SmarTrend's Sell Call (BWINB)
Comtex SmarTrend(R) - Fri Oct 09, 10:18AM CDT
SmarTrend identified a Downtrend for Baldwin & Lyons (NASDAQ:BWINB) on November 19th, 2014 at $25.49. In approximately 11 months, Baldwin & Lyons has returned 10.22% as of today's recent price of $22.88.
BWINB: 26.45 (-0.04)

Baldwin & Lyons, Inc. (Nasdaq:BWINB) to Ring The Nasdaq Stock Market Opening Bell
GlobeNewswire - Mon Oct 05, 9:00AM CDT
What:
BWINB: 26.45 (-0.04), BWINA: 24.74 (+0.04), NDAQ: 71.42 (+0.66)

Baldwin & Lyons Has Returned 16.0% Since SmarTrend Recommendation (BWINB)
Comtex SmarTrend(R) - Fri Oct 02, 9:43AM CDT
SmarTrend identified a Downtrend for Baldwin & Lyons (NASDAQ:BWINB) on November 19th, 2014 at $25.49. In approximately 11 months, Baldwin & Lyons has returned 15.95% as of today's recent price of $21.42.
BWINB: 26.45 (-0.04)

Downtrend Call Working As Baldwin & Lyons Stock Falls 12.9% (BWINB)
Comtex SmarTrend(R) - Tue Sep 15, 9:28AM CDT
SmarTrend identified a Downtrend for Baldwin & Lyons (NASDAQ:BWINB) on November 19th, 2014 at $25.49. In approximately 10 months, Baldwin & Lyons has returned 12.93% as of today's recent price of $22.19.
BWINB: 26.45 (-0.04)

Baldwin & Lyons, Inc. Announces Third Quarter 2015 Earnings Release Date and Conference Call
GlobeNewswire - Thu Sep 03, 8:28AM CDT
Baldwin & Lyons, Inc. (Nasdaq:BWINA) (Nasdaq:BWINB), today announced that management has scheduled its quarterly conference call for Thursday November 5, 2015, at 11:00 AM ET (New York time) to discuss results for the third quarter ended September 30, 2015. Results will be released prior to the opening of the financial markets on November 5, 2015, and will be available on the company's website at www.baldwinandlyons.com upon release.
BWINB: 26.45 (-0.04), BWINA: 24.74 (+0.04)

Baldwin & Lyons Down 10.6% Since SmarTrend Downtrend Call (BWINB)
Comtex SmarTrend(R) - Mon Aug 24, 5:49PM CDT
SmarTrend identified a Downtrend for Baldwin & Lyons (NASDAQ:BWINB) on November 19th, 2014 at $25.49. In approximately 9 months, Baldwin & Lyons has returned 10.61% as of today's recent price of $22.78.
BWINB: 26.45 (-0.04)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Epiclay: Game Changer for Sculptors Debuts

Updated Category News Views 11

Epiclay™ Brings New Energy to Sculpting World Folks, if ever there was a time to break the mold, it’s now, and Ace of Clay’s got us covered with Epiclay™—a fresh take on polymer clay that’s turning heads in the sculpture circuit. Over four long years, Ace of Clay, a brand that's gathered a rather colorful following through captivating sculptures and detailed...

Continue Reading
Infrared Imaging Expands with AI, SWIR: Tech Trends

Updated Category News Views 5

Infrared Imaging: The Backbone of Future Tech Kinda wild how infrared imaging's become a hot topic in tech circles. With the market expected to jump from USD 9.2 billion in 2026 to a hefty USD 12.6 billion by 2031, averaging a 6.4% growth rate, there's plenty to chew on. Even if you ain't the analytical type, it ain't hard to spot where the money's flowing. Infrared's...

Continue Reading
SACHEU Partners with AI to Harness Real Customer Insights

Updated Category News Views 4

Rethinking Beauty Industry's AI Obsession Here’s a breath of fresh air from the otherwise AI-obsessed beauty landscape: SACHEU, the brand that's been turning heads in cosmetics, decided to pair up with Limitless Labs. This partnership isn't about ceding control to machines but amplifying genuine human voices in their product development process. Yeah, it's a...

Continue Reading
IWP and SHARE Forge New Path for Filmmaker Funding

Updated Category News Views 4

Revolutionizing Film Financing The film industry has always been a tough nut to crack. Imagine trying to keep your creative baby yours without surrendering the crown jewels of intellectual property. Well, now, the cavalry with a fresh game plan has arrived, and both investors and filmmakers might be ready for another round. This isn't the typical PR fairytale; it's...

Continue Reading
Navigating Hit and Run Protocols in St. Tammany Parish

Updated Category News Views 4

When the Driver Disappears: Steps Forward Hit and run accidents can leave you feeling abandoned and unsure of what to do. In St. Tammany Parish, this scenario is all too familiar. Personal Injury Attorney Ross F. Lagarde cuts through the chaos, offering a clear path for those caught in this nightmare, explained in HelloNation's comprehensive guide. Prioritize Safety and...

Continue Reading
SureDone's Taska AI: Transforming Marketplace Listings

Updated Category News Views 5

Revolutionizing the E-Commerce Landscape Wake up and smell the innovation, folks! SureDone is rolling out Taska AI, a tool that's set to declutter the chaotic world of enterprise marketplace listings. It's no bed of roses for sellers out there, dealing with diverse channel demands and post-submission hiccups. Taska AI steps in as the seasoned handyman these sellers...

Continue Reading
Oracle Harnesses AI to Streamline Healthcare Payments

Updated Category News Views 8

Oracle Steps into Healthcare's Payment Arena You ever try solving a puzzle with half the pieces missing? Well, that's exactly what healthcare orgs have been doing with their revenue cycles. Oracle (NYSE:ORCL) thinks it’s got the missing pieces. They've announced some slick AI capabilities to grease the wheels of healthcare revenue management. But hey, I've seen grand...

Continue Reading
FSC Revives Frank Lloyd Wright's Planetarium Magic

Updated Category News Views 5

The cosmos are back on the show menu at Florida Southern College, folks. Let's dig into what that means for history buffs and star gazers alike. We're talking about the big reopening of the college's Frank Lloyd Wright designed Planetarium—a space that's been gathering dust for far too long. Dive in with me to see why this is more than just a coat of paint on an old...

Continue Reading
BlueCollar Backs SuiteWorld 2026 with Platinum Sponsorship

Updated Category News Views 6

BlueCollar Cloud Aligns with SuiteWorld 2026 If you thought the construction ERP space was just a dusty office in a backlot, think again. BlueCollar Cloud is strapping on its boots and diving into the heart of SuiteWorld 2026 with a platinum sponsorship. This isn't just a walk in the park—it's a strategic power move, aligning themselves smack-dab in the middle of...

Continue Reading
1.8M Moves in England: The Admin Maze Explained

Updated Category News Views 5

Navigating the Address Change Labyrinth Every time that welcome mat rolls out in a new spot, you're signing up for a mountain of paperwork. Sloth Move just painted a picture of the administrative mess awaiting those 1.8 million English households that decided 'new view, new digs' last year. Their analysis highlights why moving home means more than packing boxes—it's...

Continue Reading

Top 5 Most Recently Viewed Articles

Join the Class Action for Novo Nordisk Investors Today

Updated Category News Views 95

Novo Nordisk A/S Securities Class Action Opportunity Investors who purchased securities of Novo Nordisk A/S (NYSE: NVO) between specific dates have a significant opportunity to engage in a class action lawsuit. This lawsuit is rooted in claims pertaining to misrepresentation of crucial details surrounding the company's clinical trial outcomes and announcements made by the...

Continue Reading
Understanding the Potential Fed Rate Cut: NFP Insights

Updated Category News Views 116

The Implications of the NFP Report on Fed Decisions This month’s jobs report is critical, particularly due to anticipated benchmark revisions to past employment figures. These revisions may indicate more than a million jobs could be adjusted, leading to discussions about a potential rate cut by the Federal Reserve. Key Expectations for the NFP Report Analysts forecast...

Continue Reading
Explore Vegamour's Innovation in Hair Growth Supplements Today

Updated Category News Views 352

Vegamour Unveils GRO+ Advanced Hair Growth Supplements Vegamour, a leader in plant-powered biotech dedicated to enhancing hair longevity, has recently announced a groundbreaking product: the GRO+ Advanced Hair Growth & Density Supplements. This new dual-pill system is designed to combat hair thinning through a unique internal approach that prioritizes health and wellness....

Continue Reading
Coalfire Launches ISO 42001 Certification for Responsible AI Management

Updated Category News Views 384

Coalfire Pioneers ISO 42001 Certification for AI Governance Coalfire is leading the cybersecurity industry by becoming one of the first organizations accredited by the ANSI National Accreditation Board (ANAB) for the ISO/IEC 42001:2023 standard, dedicated to Artificial Intelligence governance. The Need for AI Governance As AI technologies continue to advance rapidly, the...

Continue Reading
Akeso's Ivonescimab Sets New Standards in NSCLC Treatment

Updated Category News Views 143

Akeso's Groundbreaking Clinical Trial Results Akeso, Inc. (9926.HK) is thrilled to share significant breakthroughs from its Phase III clinical study of ivonescimab, a cutting-edge PD-1/VEGF bispecific antibody designed to treat non-small cell lung cancer (NSCLC). The study, known as HARMONi-2/AK112-303, has garnered attention following its publication in The Lancet, one...

Continue Reading